{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:23:23Z","timestamp":1790360603153,"version":"4.1.0"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148429","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T18:35:22Z","timestamp":1455906922000},"page":"e0148429","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis"],"prefix":"10.1371","volume":"11","author":[{"given":"Gregor E.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Smesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam R.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berko","family":"Milleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Langbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta-Christina","family":"Hipler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Milleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Klier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Schl\u00f6gelhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Holub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Paul","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archderm.1959.01560170043008","article-title":"The cutaneous reaction to nicotinic acid (niacin)-furfuryl","volume":"79","author":"TW Murrell Jr.","year":"1959","journal-title":"AMA Arch Derm"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.1964.tb05744.x","article-title":"Treatment of Schizophrenia with Nicotinic Acid. A Ten Year Follow-Up","volume":"40","author":"A Hoffer","year":"1964","journal-title":"Acta Psychiatr Scand"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0006-3223(91)90060-Y","article-title":"Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans","volume":"29","author":"J Kleijnen","year":"1991","journal-title":"Biol Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jama.1969.03150200121025","article-title":"Adverse effects of niacin in emergent psychosis","volume":"207","author":"A Hoffer","year":"1969","journal-title":"Journal of the American Medical Association (JAMA)"},{"key":"ref5","first-page":"33","article-title":"Niacin flushing, Prostaglandin E3 and evening pimrose oil. A possible objective test monitoring therapy in schizophrenia","volume":"9","author":"DF Horrobin","year":"1980","journal-title":"Journal of Orthomolecular Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/schbul\/20.2.235","article-title":"Pain insensitivity in schizophrenia: a neglected phenomenon and some implications","volume":"20","author":"RH Dworkin","year":"1994","journal-title":"Schizophrenia Bulletin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1176\/appi.ajp.157.8.1327","article-title":"Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs","volume":"157","author":"H Hermesh","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oxfordjournals.schbul.a033407","article-title":"At issue: schizophrenia and rheumatoid arthritis: the negative association revisited","volume":"25","author":"RJ Oken","year":"1999","journal-title":"Schizophrenia Bulletin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"1","author":"DF Horrobin","year":"1977","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/341739a0","article-title":"Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus","volume":"341","author":"JH Williams","year":"1989","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2012.08.014","article-title":"A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia","volume":"141","author":"WJ van der Kemp","year":"2012","journal-title":"Schizophr Res"},{"key":"ref12","first-page":"261","article-title":"Search for the Causes of Schizophrenia Balance of the Century","author":"DF Horrobin","year":"1999"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"DF Horrobin","year":"1994","journal-title":"Schizophr Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2007.08.006","article-title":"Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia","volume":"77","author":"S Smesny","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","article-title":"The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?","volume":"41","author":"CJ Hudson","year":"1997","journal-title":"Biol Psychiatry"},{"key":"ref16","first-page":"14","article-title":"Niacin skin flush test: a research tool for studying schizophrenia","volume":"22","author":"S Nadalin","year":"2010","journal-title":"Psychiatr Danub"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","article-title":"Niacin skin flush in schizophrenia: a preliminary report","volume":"29","author":"PE Ward","year":"1998","journal-title":"Schizophr Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2001.tb11065.x","article-title":"The niacin skin flush test in schizophrenia: a replication study","volume":"55","author":"BK Puri","year":"2001","journal-title":"Int J Clin Pract"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","article-title":"A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia","volume":"26","author":"BK Puri","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study","volume":"62","author":"E Messamore","year":"2003","journal-title":"Schizophr Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"H Tavares","year":"2003","journal-title":"Schizophr Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","article-title":"Potential use of the topical niacin skin test in early psychosis\u2014a combined approach using optical reflection spectroscopy and a descriptive rating scale","volume":"37","author":"S Smesny","year":"2003","journal-title":"J Psychiatr Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","article-title":"Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia","volume":"72","author":"S Smesny","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S2215-0366(14)00082-0","article-title":"Cultures for mental health care of young people: an Australian blueprint for reform","volume":"1","author":"PD McGorry","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/138161212799316299","article-title":"The ultra high risk approach to define psychosis risk","volume":"18","author":"AR Yung","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1385\/MN:32:1:089","article-title":"Lipid signaling in neural plasticity, brain repair, and neuroprotection","volume":"32","author":"NG Bazan","year":"2005","journal-title":"Mol Neurobiol"},{"key":"ref27","first-page":"339","article-title":"Early identification and intervention in psychotic illness","volume":"64","author":"TJ Miller","year":"2000","journal-title":"Conn Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02189116","article-title":"Diagnostic validity of basic symptoms","volume":"246","author":"J Klosterkotter","year":"1996","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/138161212799316064","article-title":"Basic symptoms and the prediction of first-episode psychosis","volume":"18","author":"F Schultze-Lutter","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867411432205","article-title":"Early intervention in psychosis: evidence, evidence gaps, criticism, and confusion","volume":"46","author":"AR Yung","year":"2012","journal-title":"Aust N Z J Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/schbul\/sbm149","article-title":"Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk","volume":"34","author":"SJ Wood","year":"2008","journal-title":"Schizophr Bull"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopsych.2011.01.032","article-title":"Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies","volume":"70","author":"B Olabi","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/schbul\/sbs095","article-title":"Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition","volume":"39","author":"S Borgwardt","year":"2012","journal-title":"Schizophr Bull"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/schbul\/sbr194","article-title":"Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals","volume":"38","author":"P Allen","year":"2012","journal-title":"Schizophr Bull"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archgenpsychiatry.2010.66","article-title":"Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis","volume":"67","author":"LJ Seidman","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1017\/S0033291715000689","article-title":"Negative cognition, affect, metacognition and dimensions of paranoia in people at ultra-high risk of psychosis: a multi-level modelling analysis","volume":"45","author":"AP Morrison","year":"2015","journal-title":"Psychol Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1017\/S0033291715001373","article-title":"Investigation of metamemory functioning in the at-risk mental state for psychosis","volume":"45","author":"S Eisenacher","year":"2015","journal-title":"Psychol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.biopsych.2010.09.057","article-title":"Prediction of psychosis by mismatch negativity","volume":"69","author":"M Bodatsch","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/schbul\/sbm153","article-title":"Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading","volume":"35","author":"SS Chang","year":"2009","journal-title":"Schizophr Bull"},{"key":"ref40","first-page":"372","article-title":"Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia","volume":"20","author":"A Buretic-Tomljanovic","year":"2008","journal-title":"Psychiatr Danub"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy","volume":"22","author":"WF Gattaz","year":"1987","journal-title":"Biol Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001819","article-title":"The role of phospholipases A2 in schizophrenia","volume":"11","author":"MH Law","year":"2006","journal-title":"Mol Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2165\/00023210-200317150-00003","article-title":"Clinical potential of omega-3 fatty acids in the treatment of schizophrenia","volume":"17","author":"R Emsley","year":"2003","journal-title":"CNS Drugs"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"WS Fenton","year":"2000","journal-title":"Biol Psychiatry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-6-21","article-title":"Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?","volume":"6","author":"BM Ross","year":"2007","journal-title":"Lipids Health Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plefa.2004.03.011","article-title":"Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia","volume":"71","author":"JK Yao","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/mp.2013.7","article-title":"Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis","volume":"19","author":"S Smesny","year":"2014","journal-title":"Mol Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"GP Amminger","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plefa.2008.06.001","article-title":"The topical niacin sensitivity test: an inter- and intra-rater reliability study in healthy controls","volume":"79","author":"M Kerr","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpsychires.2004.01.007","article-title":"The influence of age and gender on niacin skin test results\u2014implications for the use as a biochemical marker in schizophrenia","volume":"38","author":"S Smesny","year":"2004","journal-title":"J Psychiatr Res"},{"key":"ref51","first-page":"79","article-title":"Incipient neurovulnerability and neuroprotection in early psychosis","volume":"37","author":"GE Berger","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"KQ Do","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"KQ Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1100\/tsw.2002.870","article-title":"Membrane pathology in schizophrenia: implication for arachidonic acid signaling","volume":"2","author":"JK Yao","year":"2002","journal-title":"ScientificWorldJournal"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"JK Yao","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"JK Yao","year":"2006","journal-title":"Dis Markers"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1020261600498","article-title":"Lipid peroxides in the free radical pathophysiology of brain diseases","volume":"18","author":"AA Farooqui","year":"1998","journal-title":"Cell Mol Neurobiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jnr.490380103","article-title":"Involvement of glutamate receptors, lipases, and phospholipases in long-term potentiation and neurodegeneration","volume":"38","author":"AA Farooqui","year":"1994","journal-title":"J Neurosci Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.plefa.2004.03.004","article-title":"Brain phospholipases A2: a perspective on the history","volume":"71","author":"AA Farooqui","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref60","first-page":"65","article-title":"Eicosanoids in synaptic transmission","volume":"8","author":"D Piomelli","year":"1994","journal-title":"Crit Rev Neurobiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02834212","article-title":"Phospholipases, lysophospholipases, and lipases and their involvement in various diseases","volume":"7","author":"AA Farooqui","year":"1987","journal-title":"Neurochem Pathol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"S Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"Suppl 1","key":"ref63","first-page":"220","article-title":"The role of eicosanoids in the brain","volume":"17","author":"D Tassoni","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2011.12.049","article-title":"Impaired monocyte activation in schizophrenia","volume":"198","author":"N Muller","year":"2012","journal-title":"Psychiatry Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/138161212799316163","article-title":"Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI\/MRS study","volume":"18","author":"GE Berger","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/acps.12265","article-title":"Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity","volume":"130","author":"J Assies","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pscychresns.2009.12.003","article-title":"Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study","volume":"182","author":"SJ Wood","year":"2010","journal-title":"Psychiatry Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/mp.2011.167","article-title":"Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals","volume":"17","author":"GP Amminger","year":"2012","journal-title":"Mol Psychiatry"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.npp.1301343","article-title":"Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia","volume":"32","author":"S Smesny","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jad.2009.12.017","article-title":"Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder","volume":"124","author":"S Smesny","year":"2010","journal-title":"J Affect Disord"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.04.027","article-title":"Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response","volume":"59","author":"RJ Mocking","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2006.07.012","article-title":"Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls","volume":"75","author":"LR Nieminen","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2009.10.004","article-title":"Omega-3 polyunsaturated fatty acids and anxiety disorders","volume":"81","author":"BM Ross","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4306\/pi.2009.6.4.264","article-title":"Depressive symptoms and brain metabolite alterations in subjects at ultra-high risk for psychosis: A preliminary study","volume":"6","author":"MS Byun","year":"2009","journal-title":"Psychiatry Investig"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/schbul\/sbs136","article-title":"Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis","volume":"40","author":"P Fusar-Poli","year":"2014","journal-title":"Schizophr Bull"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(02)00167-6","article-title":"Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group","volume":"60","author":"AR Yung","year":"2003","journal-title":"Schizophr Res"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","article-title":"Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study","volume":"33","author":"GE Berger","year":"2008","journal-title":"Neuropsychopharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T23:17:30Z","timestamp":1692227850000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148429"}},"subtitle":[],"editor":[{"given":"F. Markus","family":"Leweke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148429","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]}}}